Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Co-trimoxazole may help treat autoimmune diseases.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Apremilast showed mixed results for treating severe alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Etanercept may not prevent alopecia areata from coming back.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.